Industry News
Genes Carried By E. coli Bacteria Linked To Colon Cancer
Aug 20, 2012
Scientists at the University of Liverpool have identified a type of E. coli bacteria that may encourage the development of colon cancer. The Liverpool team had previously shown that people with colon cancer and with the inflammatory bowel diseases, Crohn's disease and ulcerative colitis, have high numbers of a sticky type of E. coli in their colons. The team have now found that E... Read More
Treatment For Cervical Disease Is Not Linked To Increased Risk Of Preterm Births
Aug 20, 2012
Treatment for cervical disease does not appear to increase the risk of subsequently giving birth prematurely, according to a study of over 44,000 women in England. The study, published online in the British Medical Journal recently, was the largest in the UK to investigate this and contradicts previous research suggesting treatment could be linked to an increased risk... Read More
Treatment For Cervical Disease Is Not Linked To Increased Risk Of Preterm Births
Aug 20, 2012
Treatment for cervical disease does not appear to increase the risk of subsequently giving birth prematurely, according to a study of over 44,000 women in England. The study, published online in the British Medical Journal recently, was the largest in the UK to investigate this and contradicts previous research suggesting treatment could be linked to an increased risk... Read More
Metabolic Protein Wields Phosphate Group To Activate Cancer-Promoting Genes
Aug 20, 2012
A metabolic protein that nourishes cancer cells also activates tumor-promoting genes by loosening part of the packaging that entwines DNA to make up chromosomes, a team led by scientists at The University of Texas MD Anderson Cancer Center reports in the Aug. 16 issue of Cell... Read More
Metabolic Protein Wields Phosphate Group To Activate Cancer-Promoting Genes
Aug 20, 2012
A metabolic protein that nourishes cancer cells also activates tumor-promoting genes by loosening part of the packaging that entwines DNA to make up chromosomes, a team led by scientists at The University of Texas MD Anderson Cancer Center reports in the Aug. 16 issue of Cell... Read More
Combination Peptide Therapies Might Offer More Effective, Less Toxic Cancer Treatment
Aug 20, 2012
Two studies suggest that two peptide agents used either together or individually with a low-dose of a standard chemotherapy drug might offer more effective cancer therapy than current standard single-drug treatments... Read More
Combination Peptide Therapies Might Offer More Effective, Less Toxic Cancer Treatment
Aug 20, 2012
Two studies suggest that two peptide agents used either together or individually with a low-dose of a standard chemotherapy drug might offer more effective cancer therapy than current standard single-drug treatments... Read More
Pan-Fried Meat Increases Risk Of Prostate Cancer, New Study Finds
Aug 19, 2012
Research from the University of Southern California (USC) and Cancer Prevention Institute of California (CPIC) found that cooking red meats at high temperatures, especially pan-fried red meats, may increase the risk of advanced prostate cancer by as much as 40 percent... Read More
Enzalutamide Adds 5 Months Survival In Late-Stage Prostate Cancer
Aug 19, 2012
Results of a phase III clinical trial of the drug Enzalutamide, published recently in the New England Journal of Medicine, show the drug extends life by an average five months in the most advanced stages of prostate cancer. "This is a major advance. Not only do we see more survival benefit than from traditional chemotherapy, but the side effects of Enzalutamide are much lower... Read More
Enzalutamide Adds 5 Months Survival In Late-Stage Prostate Cancer
Aug 19, 2012
Results of a phase III clinical trial of the drug Enzalutamide, published recently in the New England Journal of Medicine, show the drug extends life by an average five months in the most advanced stages of prostate cancer. "This is a major advance. Not only do we see more survival benefit than from traditional chemotherapy, but the side effects of Enzalutamide are much lower... Read More
Previous Page Next Page